adplus-dvertising
Connect with us

Business

There’s no ‘best’ vaccine, expert says as Canada OKs AstraZeneca shots – Globalnews.ca

Published

 on


Vaccines from Moderna, Pfizer-BioNTech and AstraZeneca-Oxford have now been approved in Canada.  While Canadians may not get a choice about which COVID-19 vaccine to take, all three offer protection against severe illness, according to experts.

“All of these vaccines are good,” Dr. Bradly Wouters, executive vice-president of science and research at the University Health Network told Global News Friday.

Read more:
What are the differences between Canada’s approved COVID-19 vaccines? Here’s what we know

Available data shows all these three vaccines have the “ability to impact hospitalization” and offer “protection against severe illness,” he said.

Which vaccine is the best?

There’s no “best vaccine” option.

Whichever vaccine is available first, “it’s going to protect you,” Wouters said.

Story continues below advertisement

Parts of the world are already facing which-is-best challenges. Astrazeneca’s vaccine for instance, was cleared for use in Britain and Europe after data suggested that it was about 70 per cent effective.

Italy’s government recently decided to reserve Pfizer and Moderna shots for the elderly and designate the Astrazeneca vaccine for younger, at-risk workers, sparking protests.

“Right now, it’s not vaccine against vaccine, it’s vaccine against virus,” Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, recently told The Associated Press.

Wouters reiterated a similar notion.

“In a pandemic, you need fast results,” he noted and the “priority is to ensure everyone gets vaccinated” and not “debate over which vaccine is better.”

“Each trial involves different people in different places,” he said, and while many may be making comparisons between vaccines from the results of different Phase 3 trials, “such comparisons are misleading,” he said.

After Pfizer and Moderna, AstraZeneca is the third shot officially authorized in the country.


Click to play video 'Health Canada official explains how AstraZeneca’s COVID-19 vaccine works'



0:59
Health Canada official explains how AstraZeneca’s COVID-19 vaccine works


Health Canada official explains how AstraZeneca’s COVID-19 vaccine works

The two doses of the Pfizer and Moderna shots were found to be about 95 per cent effective against the virus as compared to the AstraZeneca shots that stand at 62 per cent in preventing symptomatic cases.

Story continues below advertisement

However, Wouters said they will all work “as effectively as possible as long as combined with mask-wearing, handwashing and social distancing.”

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

“We must continue to follow public health guidelines, being cautious until positive cases, hospitalizations and deaths are significantly reduced nationwide,” he said.

Following Canada’s approval of AstraZeneca’s COVID-19 vaccine Friday, Procurement Minister Anita Anand cautioned against deliberation over “the sort of good or bad” vaccines.


Click to play video 'Coronavirus: Canada secures 2M doses of CoviShield vaccine, to arrive in weeks'



2:08
Coronavirus: Canada secures 2M doses of CoviShield vaccine, to arrive in weeks


Coronavirus: Canada secures 2M doses of CoviShield vaccine, to arrive in weeks

“If there is a vaccine and it’s been authorized by Health Canada, it means that it’s met standards,” Anand said during a press conference Friday.

AstraZeneca shots may not seem equal to its opponents at first glance but “these vaccines do have a use,” she said.

“We have real-world evidence from Scotland and the U.K. for people that have been dosed that have been over 80, and that has shown a significant drop in hospitalizations, to the tune of 84 per cent,” she said.

Story continues below advertisement

“The idea is to have a suite of vaccines that are available. I think Canada is hungry for vaccines, we’re putting more on the buffet table to be used.”

Standards of efficacy

Speaking of the “standards of effectiveness,” Anand said vaccines “should meet at least 50 per cent.”

“If we compare that to the influenza viruses that we authorize every year, if you look back, for example, just to last year, the effectiveness of the flu vaccine against the most common strain was about 64 per cent, across to the next common strain was about 54 per cent,” she said.

As more information becomes available from real-world use, “the efficacy” of the AstraZeneca vaccine might prove to “be much higher,” Anand added.

Read more:
Canada approves AstraZeneca’s COVID-19 vaccine

Considering all the five vaccines that are currently under review, including the Novavax and Johnson & Johnson shots, Anand emphasized that nobody has died so far from “adverse effects” of these vaccines.

“If you look across all the clinical trials of the tens of thousands of people that were involved, the number of cases of people that died from COVID-19 that got vaccine was zero. The number of people that were hospitalized because their COVID-19 disease was so severe was zero. The number of people that died because of an adverse event or an effect of the vaccine was zero,” she said.

Story continues below advertisement

The idea is “to prevent” serious illness, hospitalizations and “of course prevent death,” Anand said.

Storage and distribution

Compared to the other vaccines, the AstraZeneca shot is also easier to administer.

The vaccine can be stored, transported and handled at normal refrigerated conditions (2 to 8 C/36 to 46 F) for at least six months and administered within existing health-care settings.


Click to play video 'Cold storage of COVID-19 vaccine complicates rollout'



2:54
Cold storage of COVID-19 vaccine complicates rollout


Cold storage of COVID-19 vaccine complicates rollout – Dec 8, 2020

The Moderna and Pfizer options, meanwhile, must be stored at subzero temperatures until they’re ready to be used, at -4 F and -94 F, respectively.

This is “something we need to take into account,” Dr. Howard Njoo, Canada’s deputy chief public health officer, said during a press conference Friday.

Story continues below advertisement

He said the onboarding of the AstraZeneca vaccine is “another tool in our toolbox.”

“Following the approval of Health Canada, the efficacy stands at 62 per cent, but we have to look at the entire profile of each vaccine because this vaccine is easier to administer than Pfizer and Moderna, so this is something we need to take into account,” he said.

— With files from The Associated Press

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Politics likely pushed Air Canada toward deal with ‘unheard of’ gains for pilots

Published

 on

 

MONTREAL – Politics, public opinion and salary hikes south of the border helped push Air Canada toward a deal that secures major pay gains for pilots, experts say.

Hammered out over the weekend, the would-be agreement includes a cumulative wage hike of nearly 42 per cent over four years — an enormous bump by historical standards — according to one source who was not authorized to speak publicly on the matter. The previous 10-year contract granted increases of just two per cent annually.

The federal government’s stated unwillingness to step in paved the way for a deal, noted John Gradek, after Prime Minister Justin Trudeau made it plain the two sides should hash one out themselves.

“Public opinion basically pressed the federal cabinet, including the prime minister, to keep their hands clear of negotiations and looking at imposing a settlement,” said Gradek, who teaches aviation management at McGill University.

After late-night talks at a hotel near Toronto’s Pearson airport, the country’s biggest airline and the union representing 5,200-plus aviators announced early Sunday morning they had reached a tentative agreement, averting a strike that would have grounded flights and affected some 110,000 passengers daily.

The relative precariousness of the Liberal minority government as well as a push to appear more pro-labour underlay the prime minister’s hands-off approach to the negotiations.

Trudeau said Friday the government would not step in to fix the impasse — unlike during a massive railway work stoppage last month and a strike by WestJet mechanics over the Canada Day long weekend that workers claimed road roughshod over their constitutional right to collective bargaining. Trudeau said the government respects the right to strike and would only intervene if it became apparent no negotiated deal was possible.

“They felt that they really didn’t want to try for a third attempt at intervention and basically said, ‘Let’s let the airline decide how they want to deal with this one,'” said Gradek.

“Air Canada ran out of support as the week wore on, and by the time they got to Friday night, Saturday morning, there was nothing left for them to do but to basically try to get a deal set up and accepted by ALPA (Air Line Pilots Association).”

Trudeau’s government was also unlikely to consider back-to-work legislation after the NDP tore up its agreement to support the Liberal minority in Parliament, Gradek said. Conservative Leader Pierre Poilievre, whose party has traditionally toed a more pro-business line, also said last week that Tories “stand with the pilots” and swore off “pre-empting” the negotiations.

Air Canada CEO Michael Rousseau had asked Ottawa on Thursday to impose binding arbitration pre-emptively — “before any travel disruption starts” — if talks failed. Backed by business leaders, he’d hoped for an effective repeat of the Conservatives’ move to head off a strike in 2012 by legislating Air Canada pilots and ground crew to stick to their posts before any work stoppage could start.

The request may have fallen flat, however. Gradek said he believes there was less anxiety over the fallout from an airline strike than from the countrywide railway shutdown.

He also speculated that public frustration over thousands of cancelled flights would have flowed toward Air Canada rather than Ottawa, prompting the carrier to concede to a deal yielding “unheard of” gains for employees.

“It really was a total collapse of the Air Canada bargaining position,” he said.

Pilots are slated to vote in the coming weeks on the four-year contract.

Last year, pilots at Delta Air Lines, United Airlines and American Airlines secured agreements that included four-year pay boosts ranging from 34 per cent to 40 per cent, ramping up pressure on other carriers to raise wages.

After more than a year of bargaining, Air Canada put forward an offer in August centred around a 30 per cent wage hike over four years.

But the final deal, should union members approve it, grants a 26 per cent increase in the first year alone, retroactive to September 2023, according to the source. Three wage bumps of four per cent would follow in 2024 through 2026.

Passengers may wind up shouldering some of that financial load, one expert noted.

“At the end of the day, it’s all us consumers who are paying,” said Barry Prentice, who heads the University of Manitoba’s transport institute.

Higher fares may be mitigated by the persistence of budget carrier Flair Airlines and the rapid expansion of Porter Airlines — a growing Air Canada rival — as well as waning demand for leisure trips. Corporate travel also remains below pre-COVID-19 levels.

Air Canada said Sunday the tentative contract “recognizes the contributions and professionalism of Air Canada’s pilot group, while providing a framework for the future growth of the airline.”

The union issued a statement saying that, if ratified, the agreement will generate about $1.9 billion of additional value for Air Canada pilots over the course of the deal.

Meanwhile, labour tension with cabin crew looms on the horizon. Air Canada is poised to kick off negotiations with the union representing more than 10,000 flight attendants this year before the contract expires on March 31.

This report by The Canadian Press was first published Sept. 16, 2024.

Companies in this story: (TSX:AC)

Source link

Continue Reading

Business

Federal $500M bailout for Muskrat Falls power delays to keep N.S. rate hikes in check

Published

 on

 

HALIFAX – Ottawa is negotiating a $500-million bailout for Nova Scotia’s privately owned electric utility, saying the money will be used to prevent a big spike in electricity rates.

Federal Natural Resources Minister Jonathan Wilkinson made the announcement today in Halifax, saying Nova Scotia Power Inc. needs the money to cover higher costs resulting from the delayed delivery of electricity from the Muskrat Falls hydroelectric plant in Labrador.

Wilkinson says that without the money, the subsidiary of Emera Inc. would have had to increase rates by 19 per cent over “the short term.”

Nova Scotia Power CEO Peter Gregg says the deal, once approved by the province’s energy regulator, will keep rate increases limited “to be around the rate of inflation,” as costs are spread over a number of years.

The utility helped pay for construction of an underwater transmission link between Newfoundland and Nova Scotia, but the Muskrat Falls project has not been consistent in delivering electricity over the past five years.

Those delays forced Nova Scotia Power to spend more on generating its own electricity.

This report by The Canadian Press was first published Sept. 16, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending